Home/ Supplements/ Dhea/ DHEA Micronized 25 mg

DHEA Micronized 25 mg

product on market Tablet or Pill XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for DHEA Micronized 25 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Non-Nutrient/Non-Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Market median: 50.0mg (57 products) 17 studies — no high-quality reviews

Other Ingredients

Dicalcium Phosphate Dihydrate Microcrystaline Cellulose Croscarmellose Sodium Ascorbyl Palmitate Hydroxypropyl Cellulose Silica Coating
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take one tablet twice daily, or as directed by your healthcare professional.

Warnings & Precautions

Individuals taking medication should discuss potential interactions with their healthcare professional.

Do not use if tamper seal is damaged.

Warning: Not for use by individuals under the age of 18 years.

Do not use if pregnant or nursing.

Consult a physician or licensed, qualified healthcare professional before using this product if you have, or have a family history of, prostate cancer, prostate enlargement, heart disease, low “good” cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug.

Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effects include acne, hair loss, hair growth on the face (in women), aggressiveness, irritability, and increased levels of estrogen. Discontinue use and call a physician or licensed, qualified healthcare professional immediately if you experience rapid heartbeat, dizziness, blurred vision, or other similar symptoms.

Keep out of reach of children.

Formulation Notes

Formulated to Exclude: Wheat, gluten, yeast, soy, animal and dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

Supports healthy androgen and estrogen levels

Additional Information

Professional Use Only Not for resale on third-party websites, including, but not limited to, Amazon and eBay.

Exclusive Professional Formulas

ePV

Third-Party Verified GMP Compliant

Third-Party Verified GMP Compliant This package is completely recyclable

Metadata

Product Details

UPC / SKU8 71149 00731 7
DSLD Entry Date2020-11-21
Product TypeNon-Nutrient/Non-Botanical
FormTablet or Pill
BrandXYMOGEN
DSLD ID240168
Data Updated2026-04-11
Research

Research Evidence

30
Research Sources
49
Avg Quality
21
Rct
5
Meta Analysis
2
Systematic Review
1
Other
1
Guideline
A Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
B Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B The auxiliary effect of oral nutritional supplements on fertility in women with diminished ovarian reserve: a systematic review and meta-analysis
Meta Analysis Annals of medicine 2025 PubMed DOI
B Impact of dehydroepiandrosterone (DHEA) supplementation on testosterone concentrations and BMI in elderly women: A meta-analysis of randomized controlled trials
Meta Analysis Complementary therapies in medicine 2021 PubMed DOI
B Supplementation of dehydroepiandrosterone (DHEA) in pre- and postmenopausal women - position statement of expert panel of Polish Menopause and Andropause Society.
Guideline Ginekologia polska 2020 PubMed DOI
B Effect of Dehydroepiandrosterone and Testosterone Supplementation on Systemic Lipolysis
Rct The Journal of clinical endocrinology and metabolism 2016 PubMed DOI
C Impact of growth hormone and dehydroepiandrosterone on protein metabolism in glucocorticoid-treated patients
Rct The Journal of clinical endocrinology and metabolism 2008 PubMed DOI
C Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.
Rct The lancet. Healthy longevity PubMed DOI
C Peculiar observations in measuring testosterone in women treated with oral contraceptives supplemented with dehydroepiandrosterone (DHEA)
Rct Clinica chimica acta; international journal of clinical chemistry 2014 PubMed DOI
C Dehydroepiandrosterone improves psychological well-being in male and female hypopituitary patients on maintenance growth hormone replacement
Rct The Journal of clinical endocrinology and metabolism 2006 PubMed
View all evidence for Dhea →
Compare

Similar Products

View all Dhea products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.